Plant-based COVID-19 variation recombinant spike protein expression vector and recombinant protein using same
The present invention relates to a novel plant-based coronavirus pneumonia (COVID-19) variant recombinant spike protein expression vector and a recombinant protein using the same, in which the recombinant protein does not have the disadvantages of animal-derived recombinant proteins by using a plant...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a novel plant-based coronavirus pneumonia (COVID-19) variant recombinant spike protein expression vector and a recombinant protein using the same, in which the recombinant protein does not have the disadvantages of animal-derived recombinant proteins by using a plant expression system, and exhibits an excellent SARS-CoV-2 prevention and treatment effect, and thus, the expression vector can be used for preventing and treating SARS-CoV-2. The composition can be usefully used as a safe composition for preventing and treating COVID-19.
本发明涉及基于植物的新型冠状病毒肺炎(COVID-19)变异重组刺突蛋白表达载体及利用上述表达载体的重组蛋白,其中,利用植物表达系统,使得上述重组蛋白没有动物来源重组蛋白的缺点,并且,表现出优秀的SARS-CoV-2预防及治疗效果,因此,可有用地用作用于预防及治疗COVID-19的安全组合物。 |
---|